MedPath

Comparison of the effect of Aspirin at doses of 80 and 160 mg on the prevention of preeclampsia in women with abnormal Doppler ultrasound of the uterine artery

Phase 3
Recruiting
Conditions
Preeclampsia.
Pre-eclampsia
Registration Number
IRCT20210804052071N1
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
300
Inclusion Criteria

Pregnant mothers at 18 to 22 weeks with impaired uterine artery Doppler
Being single

Exclusion Criteria

Premature birth for reasons other than blood pressure
The mother's unwillingness to continue cooperating
Not taking the right medication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Preeclampsia. Timepoint: During pregnancy up to 40 days after delivery. Method of measurement: Mercury sphygmomanometer, urine test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath